cbdMD (YCBD) Retained Earnings (2016 - 2026)
cbdMD (YCBD) posted Retained Earnings of $188.8 million for Q4 2025, up 1.13% sequentially from $186.7 million in Q3 2025, and up 203.12% YoY from $62.3 million in Q4 2024.
cbdMD (YCBD) Retained Earnings (2016 - 2026) Analysis & Trends
cbdMD has reported Retained Earnings for 10 years, with the latest figure at $188.8 million in Q4 2025.
- Quarterly Retained Earnings rose 203.12% year-over-year to $188.8 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $188.8 million (up 203.12% YoY) and the FY2025 annual result came in at $186.7 million, up 2596436.63% from the prior year.
- Retained Earnings rose to $188.8 million in Q4 2025 per YCBD's latest filing, from $186.7 million in the prior quarter.
- Over five years, Retained Earnings peaked at $188.8 million in Q4 2025 and troughed at -$183.1 million in Q4 2024.
- A 5-year average of $22.9 million and a median of -$6000.0 in 2024 frame the typical range for Retained Earnings.
- The sharpest annual moves came in 2024 and 2025: Retained Earnings slumped 199.82% in 2024, then jumped 2596436.63% in 2025.
- Over 5 years, Retained Earnings stood at $177.8 million in 2021, then advanced by 0.6% to $178.9 million in 2022, then rose by 2.51% to $183.4 million in 2023, then plunged by 199.82% to -$183.1 million in 2024, then soared by 203.12% to $188.8 million in 2025.
- According to Business Quant data, Retained Earnings over the past three periods registered $188.8 million, $186.7 million, and -$179.1 million for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | 37.15 Bn |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | 28.26 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | 14.65 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | 4.18 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | 9.16 Bn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 18.56 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | 724.00 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 8.88 Bn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | 3.75 Bn |
| 10 | cbdMD | 5.41 Mn | 3.29 Mn | 3.04 Mn | 190.03 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 190.03 Mn |
| Dec 31, 2025 | 188.76 Mn |
| Sep 30, 2025 | 186.65 Mn |
| Jun 30, 2025 | -179.10 Mn |
| Dec 31, 2024 | -183.05 Mn |
| Sep 30, 2024 | -7,189.00 |
| Jun 30, 2024 | -180.91 Mn |
| Mar 31, 2024 | -6,000.00 |
| Dec 31, 2023 | 183.39 Mn |
| Sep 30, 2023 | -174.36 Mn |
| Jun 30, 2023 | -157.49 Mn |
| Mar 31, 2023 | -154.72 Mn |
| Dec 31, 2022 | 178.91 Mn |
| Sep 30, 2022 | 178.84 Mn |
| Jun 30, 2022 | 178.33 Mn |
| Mar 31, 2022 | 179.12 Mn |
| Dec 31, 2021 | 177.84 Mn |
| Sep 30, 2021 | -73.34 Mn |
| Jun 30, 2021 | -68.98 Mn |
| Mar 31, 2021 | 155.78 Mn |